SEC24A Deficiency Lowers Plasma Cholesterol Through Reduced PCSK9 Secretion

Xiao-Wei Chen,He Wang,Kanika Bajaj,Pengcheng Zhang,Zhuo-Xian Meng,Danjun Ma,Yongsheng Bai,Hui-Hui Liu,Elizabeth Adams,Andrea Baines,Genggeng Yu,Maureen A. Sartor,Bin Zhang,Zhengping Yi,Jiandie Lin,Stephen G. Young,Randy Schekman,David Ginsburg
DOI: https://doi.org/10.7554/elife.00444
IF: 7.7
2013-01-01
eLife
Abstract:The secretory pathway of eukaryotic cells packages cargo proteins into COPII-coated vesicles for transport from the endoplasmic reticulum (ER) to the Golgi. We now report that complete genetic deficiency for the COPII component SEC24A is compatible with normal survival and development in the mouse, despite the fundamental role of SEC24 in COPII vesicle formation and cargo recruitment. However, these animals exhibit markedly reduced plasma cholesterol, with mutations in Apoe and Ldlr epistatic to Sec24a, suggesting a receptor-mediated lipoprotein clearance mechanism. Consistent with these data, hepatic LDLR levels are up-regulated in SEC24A-deficient cells as a consequence of specific dependence of PCSK9, a negative regulator of LDLR, on SEC24A for efficient exit from the ER. Our findings also identify partial overlap in cargo selectivity between SEC24A and SEC24B, suggesting a previously unappreciated heterogeneity in the recruitment of secretory proteins to the COPII vesicles that extends to soluble as well as trans-membrane cargoes.
What problem does this paper attempt to address?